Alex Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 47

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $5.07M

  • Investors
  • 6

Alex Therapeutics General Information

Description

Developer of disease and drug-specific companion applications designed to democratize healthcare through psychology, design, and technology. The company offers evidence-based digital interventions that deliver novel and personalized care, it also provides platforms for obesity treatment, breast cancer treatment, and nicotine addiction treatment, providing users with various self-healthcare solutions and digital applications.

Contact Information

Website
www.alextherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Upplandsgatan 7
  • 111 23 Stockholm
  • Sweden
Primary Industry
Other Healthcare Technology Systems
Other Industries
Clinics/Outpatient Services
Vertical(s)
Digital Health, HealthTech
Corporate Office
  • Upplandsgatan 7
  • 111 23 Stockholm
  • Sweden

Alex Therapeutics Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alex Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 05-Mar-2023 $5.07M Completed Generating Revenue
3. Grant 04-Jun-2021 Completed Generating Revenue
2. Early Stage VC 31-Dec-2020 $589K $758K Completed Generating Revenue
1. Early Stage VC 23-Jul-2018 $169K $169K Completed Generating Revenue
To view Alex Therapeutics’s complete valuation and funding history, request access »

Alex Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preference
Preference
To view Alex Therapeutics’s complete cap table history, request access »

Alex Therapeutics Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Alex Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202219591-D0 Digital therapy Inactive 22-Dec-2022
US-20240207230-A1 Method of treating a patient diagnosed with an interstitial lung disease Pending 22-Dec-2022
US-20240207231-A1 Method of treating a patient diagnosed with an interstitial lung disease Pending 22-Dec-2022
US-20240207232-A1 Method of treating a patient diagnosed with an interstitial lung disease Pending 22-Dec-2022 A61K31/506

Alex Therapeutics Executive Team (9)

Name Title Board Seat
John Drakenberg Co-Founder & Chief Executive Officer
Paul Kirchmeier Chief Operating Officer
Meera Montan Director of Growth (Interim)
Kimmy Bolke Chief Product Officer
Maria Rickardsson Chief Quality & Regulatory Officer
You’re viewing 5 of 9 executive team members. Get the full list »

Alex Therapeutics Board Members (7)

Name Representing Role Since
Hans-Peter Frank Self Chairman
Ingrid Teigland Akay MD Hadean Ventures Board Member
Lars Jensen Self Board Member
Marko Kuisma Innovestor Board Member
You’re viewing 4 of 7 board members. Get the full list »

Alex Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alex Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bonit Capital Family Office Minority
Hadean Ventures Venture Capital Minority
Innovestor Venture Capital Minority
Scale Capital Venture Capital Minority
Vinnova Government
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Alex Therapeutics FAQs

  • When was Alex Therapeutics founded?

    Alex Therapeutics was founded in 2018.

  • Who is the founder of Alex Therapeutics?

    John Drakenberg and Oliver Fleetwood are the founders of Alex Therapeutics.

  • Who is the CEO of Alex Therapeutics?

    John Drakenberg is the CEO of Alex Therapeutics.

  • Where is Alex Therapeutics headquartered?

    Alex Therapeutics is headquartered in Stockholm, Sweden.

  • What is the size of Alex Therapeutics?

    Alex Therapeutics has 47 total employees.

  • What industry is Alex Therapeutics in?

    Alex Therapeutics’s primary industry is Other Healthcare Technology Systems.

  • Is Alex Therapeutics a private or public company?

    Alex Therapeutics is a Private company.

  • What is Alex Therapeutics’s current revenue?

    The current revenue for Alex Therapeutics is .

  • How much funding has Alex Therapeutics raised over time?

    Alex Therapeutics has raised $5.83M.

  • Who are Alex Therapeutics’s investors?

    Bonit Capital, Hadean Ventures, Innovestor, Scale Capital, and Vinnova are 5 of 6 investors who have invested in Alex Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »